Depomed stock
Assertio Therapeutics, Inc. (formally Depomed, Inc.) is an American specialty pharmaceutical By March 2019, Assertio's stock had lost half its value since 2016. In September 2019, Crain's Chicago Business argued that Assertio's Feb 28, 2018 As of 3:08 p.m. EST, the stock had settled to an 11.8% loss. A finger pointing to a negative stock chart on a screen. Image source: Getty Images. Depomed, Inc. (delisted) stock quote and DEPO charts. Latest stock price today and the US's most active stock market forums. ASRT | Complete Assertio Therapeutics Inc. stock news by MarketWatch. View real-time DepoMed stock price target raised to $8 from $6 at UBS. Dec. 7, 2017
DEPO - TheStreet
Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER. By Melissa Angell. Stock futures rise ahead of first trading day of 2017. By Keris Alison Lahiff. Jan 3, 2017 8:42 AM EST. DEPO Interactive Stock Chart | Depomed, Inc. Stock - Yahoo ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. ASRT Stock Price | Assertio Therapeutics Inc. Stock Quote ... DepoMed stock price target cut to $51 from $66 at UBS. Aug. 15, 2017 at 9:55 a.m. ET by Tomi Kilgore. DepoMed Q2 rev. $100.4 million vs. expectations $100.1 million. Aug. 7, Assertio Therapeutics
- DEPO - Stock Price Today - Zacks
Stock analysis for Assertio Therapeutics Inc (DEPO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Here's what Wall Street expects from Depomed's earnings ... Depomed is reporting Q4 earnings on March 9. Wall Street analysts expect Depomed will release earnings per share of $0.100. Watch Depomed stock price move in real-time ahead here. Depomed will
Why Depomed (DEPO) Stock Is Surging Today | InvestorPlace
Depomed Stock Quote. DMI - Stock Price, News, Charts ...
Nov 19, 2015 Horizon first made an all-stock offer to buy Depomed in a letter sent May Depomed share, which valued the company at $17.88 a share as of
- DEPO - Stock Price Today - Zacks
Why Depomed (DEPO) Stock Is Surging Today | InvestorPlace May 09, 2016 · Depomed’s full-year guidancce has been slightly altered, moving from in the range of $485 million to $525 million, to the range of $490 million to $520 million. DEPO stock is up 14.7% Monday Assertio Therapeutics Inc., ASRT Quick Chart - (NAS) ASRT ... DepoMed stock price target raised to $8 from $6 at UBS MarketWatch. Monday, December 04, 2017. 05:04 PM ET. Depomed farms out Nucynta sales, will lay off 40% of company MarketWatch. 04:34 PM ET. Depomed to reduce staff by 40%, move headquarters out of California MarketWatch. 04:33 PM ET.